 |
About IPG
Integrated Plant Genetics, Inc. (IPG) is a development stage biotechnology
company, in business to develop, produce and license new genetic technologies for the purpose of
horticultural, agricultural and forest tree improvement and disease control. The Company currently
provides gene engineering services to industry through research contracts and also disease resistance genes and
freedom-to-operate technologies, including plant transformation technologies and methods through our marketing
partners. We are currently devoping genetic technologies to make plants resistant
to diseases for which there is presently no or little resistance or tolerance. As IPG expands and its
technology improves, we anticipate licensing our improved genetic traits ("genetic software") to established
plant nurseries and seed producers.
|
|
|
|
IPG's offices, research laboratory and transgenic plant production
facilities are located in Progress Corporate Park in Alachua, Florida, approximately 18 miles from the University of Florida campus. Testing of transgenic plants is performed offsite at several federally- and State-approved locations.
|
|
IPG’s core technologies,
DiseaseBlock and
enabling plant transformation technologies
represent a paradigm shift in scientific thinking about methods to control plant diseases.
Although traditional breeding methods have relied on plant resistance genes and natural
resistance mechanisms, it is a fact that most plant resistance genes have been defeated
by evolving pathogen populations. Recent success in the control of virus diseases of plants
by genetic engineering does not depend upon or even utilize traditional plant resistance genes.
Rather such control was achieved by first understanding the mechanism by which viruses caused
disease, and then blocking critical parts of the mechanism. Similarly, IPG's DiseaseBlock is non-toxic and does not directly kill bacterial plant pathogens such as citrus greening or canker, but rather blocks a
mechanism by which bacterial pathogens defends themselves against host plant defenses.
IPG’s core technologies, including plant transformation and disease resistance technologies, provide the platforms for future development of specific
applications to control plant diseases. Some of these technologies are partly owned by the University of Florida and are exclusively licensed to IPG for sublicensing.
Our History: IPG is a Delaware C-Corporation, founded and incorporated by Dr. Dean Gabriel in 1998. The Company became a Sid Martin Biotechnology Development Institute (BDI) Licensee in Progress Corporate Park in 1998, and graduated from the BDI in July, 2009.
Grants and Awards: IPG has been awarded six federal grants to further develop transgenic
plant technologies, including SBIR grant awards from USDA and from NSF. In
addition, IPG was awarded a contract from USDA's Animal and Plant Health Inspection Service (APHIS)
to develop citrus trees resistant to citrus greening.
For general inquiries, please send e-mail to
info@ipgenetics.com. For web site errors or content issues, please e-mail
webmaster@ipgenetics.com.
Copyright © 2001-2009 Integrated Plant Genetics, Inc. -- All Rights Reserved
|
|
|
|
